Vir Biotechnology Inc (VIR)

Exchange
NASDAQ
Symbol
VIR
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.
Country
USA

Stock price

At close: August 20, 2025

  • Open
    4.33
  • High
    4.47
  • Low
    4.28
  • Close
    4.36
  • Volume
    1,083,440

Financial ratios

Dec 31, 2024